John F. Thero - Feb 4, 2022 Form 3 Insider Report for Cyteir Therapeutics, Inc. (CYT)

Role
Director
Signature
By: /s/ Andrew Gengos, Attorney-in-Fact
Stock symbol
CYT
Transactions as of
Feb 4, 2022
Transactions value $
$0
Form type
3
Date filed
2/7/2022, 07:26 AM
Previous filing
Jan 6, 2022
Next filing
May 12, 2022

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney